期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

儿童和青少年侵袭性成熟B细胞非霍奇金淋巴瘤诊疗专家共识 被引量：9

Experts consensus on current management of children and adolescents with aggressive mature B-cell non-Hodgkin lymphoma
原文传递
导出
摘要 成熟B细胞非霍奇金淋巴瘤(B-NHL)占儿童和青少年非霍奇金淋巴瘤(NHL)的50%~60%。以伯基特淋巴瘤(BL)/白血病(B-AL)和弥漫大B细胞淋巴瘤(DLBCL)最为常见。现今高侵袭的儿童和青少年成熟B-NHL已经成为可治愈性儿童肿瘤性疾病。本共识对近10年儿童和青少年BL/B-AL和DLBCL的一线诊治方法进行汇总,以期为临床规范化治疗提供循证依据。
作者 无 高怡瑾 李小秋 无;Gao Yijin(The Subspecialty Group of Oncology;the Society of Pediatrics;Chinese Medical Association;the Subspecialty Group of Hematology;Department of Hematology/Oncology,Shanghai Children's Medical Center,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China)
机构地区 中华医学会儿科学分会肿瘤学组 中华医学会儿科学分会血液学组 中国抗癌协会小儿肿瘤专业委员会 中华儿科杂志编辑委员会 上海交通大学医学院附属上海儿童医学中心血液/肿瘤科 复旦大学附属肿瘤医院
出处 《中华儿科杂志》 CAS CSCD 北大核心 2020年第10期790-795,共6页 Chinese Journal of Pediatrics
关键词 B细胞非霍奇金淋巴瘤 伯基特淋巴瘤 规范化治疗 儿童和青少年 肿瘤性疾病 性成熟 专家共识 循证依据
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献1

二级参考文献13

  • 1Brugibres L, Le Deley MC, Rosolen A, et al. Impact of themethotrexate administration dose on the need for intratheeal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the E1CNHL Group. J Clin Onco1,2009,27 : 897-903.
  • 2Seidemann K, Tiemann M, Schrappe M, et al. Short-pulse B-non- l-Iodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin- Frankfurt-Munster Group Trial NHL-BFM 90. Blood, 2001,97: 3699-3706.
  • 3Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood, 2000,95:416-421.
  • 4Sandlund JT, Pui CH, Zhou Y, et al. Effective treatment of advanced-stage childhood |ymphoblastie lymphoma v,,ithout prophylactic cranial irradiation: results of St Jude NHL13 study. Leukemia ,2009,23 : 1127-1130.
  • 5Burkhardt B, Woessmann W, Zimmermann M, et al. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage Ⅲ or IV lymphoblastic lymphoma. J Clin 0ncol,2006,24:491- 499.
  • 6Mann G, Altarbaschi A, Steiner M, et al. Early and reliable diagalosis of non-Hodgkin lymphoma in childhood and adolescence: contribution of cytomorpholog7 and flow cytometric immunophenotyping. Pediatr Hematol Oncol,2006,23:167-176.
  • 7Swerdlow SH, Campo E, Harris NL, et al. Patholog? and geneticsof tumours of hematopoietic and lymphoid tissues. World Health Organization classification of tumours ( ed 4th). Lyon :International Agency for Research on Cancer Press, 2008:270-299.
  • 8Micheal P. Link and Howard Weinstein. Malignant Non-Hodgkin lymphoma in Principle and Practice of Pediatric Oncology. Philip A Pizzo, David G Poplock. 5th ed. Philadelphia. New York: LWW. corn ,2006:722-747.
  • 9Woessmann W, Seidemann K, Mann G. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood,2005,105:948-958.
  • 10Patte C, Auperin A, Gerrard M. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non- Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood, 2007, 109:2773-2780.

共引文献51

同被引文献71

引证文献9

二级引证文献18

中华儿科杂志
2020年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部